Asensus Surgical to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
20 Maio 2021 - 7:55AM
Business Wire
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
patient to pioneer a new era of Performance-Guided Surgery™,
announced today that Anthony Fernando, President and Chief
Executive Officer, and Shameze Rampertab, Executive Vice President
and Chief Financial Officer, will participate in the Oppenheimer
MedTech, Tools & Diagnostics Summit taking place May 26,
2021.
The Company’s presentation will be available on-demand beginning
May 26, 2021 at 8:00 am ET.
The on-demand conference presentation will be available online
on the investor relations page of the Company’s website at
https://ir.asensus.com/events-and-presentations. Replays of the
webcasts will be archived on the website for approximately 90
days.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking the clinical intelligence to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the
Senhance® Surgical System powered by the Intelligent Surgical Unit™
(ISU™) to increase surgeon control and reduce surgical variability.
With the addition of machine vision, augmented intelligence, and
deep learning capabilities throughout the surgical experience, we
intend to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the US, EU, Japan,
Russia, and select other countries. For a complete list of
indications for use, visit: www.senhance.com/indications. For more
information, visit www.asensus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210520005191/en/
INVESTOR CONTACT: Mark Klausner or Mike Vallie,
443-213-0499 invest@asensus.com or MEDIA CONTACT: Kristin
Schaeffer CG Life kschaeffer@cglife.com
Asensus Surgical, Inc. (NYSE:ASXC)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Asensus Surgical, Inc. (NYSE:ASXC)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
Notícias em tempo-real sobre Asensus Surgical, Inc. da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Asensus Surgical, Inc.